Cargando…

Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study

OBJECTIVE: Randomised controlled trials (RCTs) are often considered as the gold standard for assessing new health interventions. Patients are randomly assigned to receive an intervention or control. The effect of the intervention can be estimated by comparing outcomes between groups, whose prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Chenglin, Beyene, Joseph, Browne, Gina, Thabane, Lehana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067862/
https://www.ncbi.nlm.nih.gov/pubmed/24939814
http://dx.doi.org/10.1136/bmjopen-2014-005362
_version_ 1782322350077771776
author Ye, Chenglin
Beyene, Joseph
Browne, Gina
Thabane, Lehana
author_facet Ye, Chenglin
Beyene, Joseph
Browne, Gina
Thabane, Lehana
author_sort Ye, Chenglin
collection PubMed
description OBJECTIVE: Randomised controlled trials (RCTs) are often considered as the gold standard for assessing new health interventions. Patients are randomly assigned to receive an intervention or control. The effect of the intervention can be estimated by comparing outcomes between groups, whose prognostic factors are expected to balance by randomisation. However, patients’ non-compliance with their assigned treatment will undermine randomisation and potentially bias the estimate of treatment effect. Through simulation, we aim to compare common approaches in analysing non-compliant data under different non-compliant scenarios. SETTINGS: Based on a real study, we simulated hypothetical trials by varying three non-compliant factors: the type, randomness and degree of non-compliance. We compared the intention-to-treat (ITT), as-treated (AT), per-protocol (PP), instrumental variable (IV) and complier average casual effect (CACE) analyses to estimate large (50% improvement over the control), moderate (25% improvement) and null (same as the control) treatment effects. Different approaches were compared by the bias of estimate, mean square error (MSE) and 95% coverage of the true value. RESULTS: For a large or moderate treatment effect, the ITT estimate was considerably biased in all scenarios. The AT, PP, IV and CACE estimates were unbiased when non-compliant behaviours were random. The IV estimate was unbiased when non-compliant behaviours were symmetrically dependent on patients’ conditions. The PP estimate was mostly unbiased when patients in the control group did not have access to the intervention. When the intervention was not different from the control, the ITT was less biased than the other approaches. Similar results were found when comparing the MSE and 95% coverage. CONCLUSIONS: The standard ITT analysis under non-compliance is biased when the intervention has a moderate or large effect. Alternative analyses can provide unbiased or less biased estimates. Based on the results, we make some suggestions on choosing optimal approaches for analysing specific non-compliant scenarios.
format Online
Article
Text
id pubmed-4067862
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40678622014-06-25 Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study Ye, Chenglin Beyene, Joseph Browne, Gina Thabane, Lehana BMJ Open Research Methods OBJECTIVE: Randomised controlled trials (RCTs) are often considered as the gold standard for assessing new health interventions. Patients are randomly assigned to receive an intervention or control. The effect of the intervention can be estimated by comparing outcomes between groups, whose prognostic factors are expected to balance by randomisation. However, patients’ non-compliance with their assigned treatment will undermine randomisation and potentially bias the estimate of treatment effect. Through simulation, we aim to compare common approaches in analysing non-compliant data under different non-compliant scenarios. SETTINGS: Based on a real study, we simulated hypothetical trials by varying three non-compliant factors: the type, randomness and degree of non-compliance. We compared the intention-to-treat (ITT), as-treated (AT), per-protocol (PP), instrumental variable (IV) and complier average casual effect (CACE) analyses to estimate large (50% improvement over the control), moderate (25% improvement) and null (same as the control) treatment effects. Different approaches were compared by the bias of estimate, mean square error (MSE) and 95% coverage of the true value. RESULTS: For a large or moderate treatment effect, the ITT estimate was considerably biased in all scenarios. The AT, PP, IV and CACE estimates were unbiased when non-compliant behaviours were random. The IV estimate was unbiased when non-compliant behaviours were symmetrically dependent on patients’ conditions. The PP estimate was mostly unbiased when patients in the control group did not have access to the intervention. When the intervention was not different from the control, the ITT was less biased than the other approaches. Similar results were found when comparing the MSE and 95% coverage. CONCLUSIONS: The standard ITT analysis under non-compliance is biased when the intervention has a moderate or large effect. Alternative analyses can provide unbiased or less biased estimates. Based on the results, we make some suggestions on choosing optimal approaches for analysing specific non-compliant scenarios. BMJ Publishing Group 2014-06-17 /pmc/articles/PMC4067862/ /pubmed/24939814 http://dx.doi.org/10.1136/bmjopen-2014-005362 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Research Methods
Ye, Chenglin
Beyene, Joseph
Browne, Gina
Thabane, Lehana
Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
title Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
title_full Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
title_fullStr Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
title_full_unstemmed Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
title_short Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
title_sort estimating treatment effects in randomised controlled trials with non-compliance: a simulation study
topic Research Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067862/
https://www.ncbi.nlm.nih.gov/pubmed/24939814
http://dx.doi.org/10.1136/bmjopen-2014-005362
work_keys_str_mv AT yechenglin estimatingtreatmenteffectsinrandomisedcontrolledtrialswithnoncomplianceasimulationstudy
AT beyenejoseph estimatingtreatmenteffectsinrandomisedcontrolledtrialswithnoncomplianceasimulationstudy
AT brownegina estimatingtreatmenteffectsinrandomisedcontrolledtrialswithnoncomplianceasimulationstudy
AT thabanelehana estimatingtreatmenteffectsinrandomisedcontrolledtrialswithnoncomplianceasimulationstudy